We are live on ! Find out more
JAM

JW Asset Management Portfolio holdings

AUM $244M
1-Year Est. Return 71.51%
This Fund
S&P 500
This Quarter Est. Return
+22.9%
1 Year Est. Return
+71.51%
3 Year Est. Return
+125.61%
5 Year Est. Return
+131.61%
10 Year Est. Return
+2,490.27%
AUM
$243M
AUM Growth
+$48.6M
Cap. Flow
+$7.09M
Cap. Flow %
2.92%
Top 10 Hldgs %
100%
Holding
13
New
2
Increased
1
Reduced
–
Closed
5

Top Buys

Rank Stock Value
1
CPRX
Catalyst Pharmaceutical
CPRX
+$8.67M
2
NVO
Novo Nordisk
NVO
+$5.22M
3
CELH icon
Celsius Holdings
CELH
+$4.46M

Top Sells

Rank Stock Value
1
QDEL icon
QuidelOrtho
QDEL
+$1.13M
2
HMCOU
HumanCo Acquisition Corp. Unit
HMCOU
+$847K
3
MSOS icon
AdvisorShares Pure US Cannabis ETF
MSOS
+$534K

Sector Composition

Rank Sector Weight
1 Healthcare 95.39%
2 Consumer Staples 3.68%
3 Materials 0.51%
4 Financials 0.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ESTA icon
1
Establishment Labs
ESTA
$2.7B
$210M 86.23%
3,192,485
– –
CPRX
2
DELISTED
Catalyst Pharmaceutical
CPRX
$10.5M 4.31%
+563,392
New +$8.67M
CELH icon
3
Celsius Holdings
CELH
$7.53B
$8.95M 3.68%
258,114
+136,614
+112% +$4.46M
NVO
4
Novo Nordisk
NVO
$225B
$6.02M 2.48%
+89,000
New +$5.22M
HZNP
5
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$5.77M 2.37%
50,673
– –
IDR icon
6
Idaho Strategic Resources
IDR
$456M
$1.24M 0.51%
217,151
– –
MSAC
7
DELISTED
Medicus Sciences Acquisition Corp. Class A Ordinary Share
MSAC
$1.01M 0.41%
100,000
– –
MSACW
8
DELISTED
Medicus Sciences Acquisition Corp. Warrant
MSACW
$1K ﹤0.01%
11,110
– –
META icon
9
PUT
Meta Platforms (Facebook)
META
$1.51T
– –
-30,000
Closed -$4.07M
MSOS icon
10
AdvisorShares Pure US Cannabis ETF
MSOS
$830M
– –
-59,913
Closed -$534K
QDEL icon
11
QuidelOrtho
QDEL
$1.14B
– –
-15,868
Closed -$1.13M
QQQ icon
12
PUT
Invesco QQQ Trust
QQQ
$445B
– –
-17,500
Closed -$4.68M
HMCOU
13
DELISTED
HumanCo Acquisition Corp. Unit
HMCOU
– –
-85,000
Closed -$847K

Similar funds

SC
Schulhoff & Co Cincinnati, Ohio $243M AUM 17.47% 1-Year Est. Return
HCM
Hutner Capital Management Manchester, Vermont $243M AUM 10.01% 1-Year Est. Return
SC
Solstein Capital Menlo Park, California $244M AUM 29.05% 1-Year Est. Return
HBS
Howard Bailey Securities Fort Wayne, Indiana $243M AUM 13.36% 1-Year Est. Return
GIM
GE Investment Management Norwalk, Connecticut $244M AUM 41.62% 1-Year Est. Return
IFO
Independent Family Office Albany, New York $243M AUM 21.81% 1-Year Est. Return
VG
Visualize Group New York $243M AUM 6.21% 1-Year Est. Return
CP
Creekside Partners Petaluma, California $243M AUM 20.23% 1-Year Est. Return

JW Asset Management's Q4 2022 Portfolio in Review

As of Q4 2022, JW Asset Management held 13 positions worth $243M, up 25% from $194M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

JW Asset Management's Q4 2022 filing shows 2 new, 1 increased and 5 closed positions. Its largest new stake was Catalyst Pharmaceutical: 563,392 shares worth $10.5M. The largest sale was QuidelOrtho, an estimated $1.13M.

By sector, the portfolio is most concentrated in Healthcare at 95% of assets, up from 92% a quarter earlier, followed by Consumer Staples and Materials.

  • JW Asset Management's largest Q4 2022 buy was Catalyst Pharmaceutical: 563,392 shares worth $10.5M.
  • JW Asset Management added most to Celsius Holdings in Q4 2022, an estimated $4.46M increase.
  • JW Asset Management fully exited QuidelOrtho in Q4 2022, selling an estimated $1.13M.
  • JW Asset Management's ten largest holdings make up 100% of its $243M portfolio in Q4 2022.
  • JW Asset Management opened 2 new positions and closed 5 in Q4 2022.
  • JW Asset Management's portfolio value rose 25% quarter-over-quarter to $243M.

Based on JW Asset Management's 13F filing for Q4 2022, filed 10 Feb 2023.